In some cases, Semaglu-1 (4mg/3ml) Pfp Injection 1's may cause side effects such as nausea, vomiting, diarrhoea, constipation, abdominal discomfort, dizziness, or altered taste
And for women struggling with obesity, insulin resistance, metabolic syndrome, high cholesterol, or elevated cardiovascular risk, GLP-1 medications can absolutely be powerful tools that improve long-term health outcomes
However, comprehensive clinical trials are needed to validate its efficacy
Please refer to the product packaging
Start your intake What Happens When You Stop Taking GLP-1 Therapy Weight regain after GLP-1 discontinuation is common but not inevitable
For example, in a study by Mikhalkova et al